Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Zhou, Shixin  [Clear All Filters]
2013
Li Y, Li Z, Zhou S, Wen J, Geng B, Yang J, Cui Q. Genome-Wide Analysis of Human MicroRNA Stability. Biomed Res Int. 2013;2013:368975.
2016
Bai Y, Kan S, Zhou S, Wang Y, Xu J, Cooke JP, Wen J, Deng H. Erratum: Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA. Cell Discov. 2016;2:15052.
2018
Zhou S, Zhao H, Feng R, Ding L, Li Z, Deng C, He Q, Liu Y, Song B, Li Y. Application of amphiphilic fluorophore-derived nanoparticles to provide contrast to human embryonic stem cells without affecting their pluripotency and to monitor their differentiation into neuron-like cells. Acta Biomater. 2018.
Teng R, Zhao J, Zhao Y, Gao J, Li H, Zhou S, Wang Y, Sun Q, Lin Z, Yang W, et al. Chimeric Antigen Receptor-modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model. J Immunother. 2018.
2020
Su W, Guo R, Yuan F, Li Y, Li X, Zhang Y, Zhou S, Fan L. Correction to "Red-Emissive Carbon Quantum Dots for Nuclear Drug Delivery in Cancer Stem Cells". J Phys Chem Lett. 2020:4345.
Su W, Guo R, Yuan F, Li Y, Li X, Zhang Y, Zhou S, Fan L. Red-Emissive Carbon Quantum Dots for Nuclear Drug Delivery in Cancer Stem Cells. J Phys Chem Lett. 2020:1357-1363.
2023
Meng F, Zhang S, Xie J, Zhou Y, Wu Q, Lu B, Zhou S, Zhao X, Li Y. Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells. J Hematol Oncol. 2023;16(1):62.